Cargando…
Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240297/ https://www.ncbi.nlm.nih.gov/pubmed/35695321 http://dx.doi.org/10.3348/kjr.2022.0110 |
Ejemplares similares
-
Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma
por: Ashoor, Arwa, et al.
Publicado: (2022) -
Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous
por: Finsterer, Josef
Publicado: (2022) -
Post-SARS-CoV-2 vaccination facial palsy requires extensive work-up and appropriate treatment
por: Finsterer, Josef
Publicado: (2022) -
Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023) -
There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)